Schwartz Christoph, Ueberschaer Moritz F, Rautalin Ilari, Grauvogel Jürgen, Bissolo Marco, Masalha Waseem, Steiert Christine, Schnell Oliver, Beck Jürgen, Ebel Florian, Bervini David, Raabe Andreas, Eibl Thomas, Steiner Hans-Herbert, Schebesch Karl-Michael, Shlobin Nathan A, Nandoliya Khizar R, Youngblood Mark W, Chandler James P, Magill Stephen T, Romagna Alexander, Lehmberg Jens, Fuetsch Manuel, Spears Julian, Rezai Arwin, Ladisich Barbara, Demetz Matthias, Griessenauer Christoph J, Niemelä Mika, Korja Miikka
Department of Neurosurgery, Helsinki University and Helsinki University Hospital, Helsinki, Finland.
Department of Neurosurgery, University Hospital Salzburg, Paracelsus Medical University Salzburg, Ignaz-Harrer-Str. 79, 5020 , Salzburg, Austria.
J Neurooncol. 2024 Oct;170(1):89-100. doi: 10.1007/s11060-024-04780-6. Epub 2024 Sep 4.
To assess whether the Modified 5 (mFI-5) and 11 (mFI-11) Factor Frailty Indices associate with postoperative mortality, complications, and functional benefit in supratentorial meningioma patients aged over 80 years.
Baseline characteristics were collected from eight centers. Based on the patients' preoperative status and comorbidities, frailty was assessed by the mFI-5 and mFI-11. The collected scores were categorized as "robust (mFI=0)", "pre-frail (mFI=1)", "frail (mFI=2)", and "significantly frail (mFI≥3)". Outcome was assessed by the Karnofsky Performance Scale (KPS); functional benefit was defined as improved KPS score. Additionally, we evaluated the patients' functional independence (KPS≥70) after surgery.
The study population consisted of 262 patients (median age 83 years) with a median preoperative KPS of 70 (range 20 to 100). The 90-day and 1-year mortality were 9.0% and 13.2%; we recorded surgery-associated complications in 111 (42.4%) patients. At last follow-up within the postoperative first year, 101 (38.5%) patients showed an improved KPS, and 183 (69.8%) either gained or maintained functional independence. "Severely frail" patients were at an increased risk of death at 90 days (OR 16.3 (CI95% 1.7-158.7)) and one year (OR 11.7 (CI95% 1.9-71.7)); nine (42.9%) of severely frail patients died within the first year after surgery. The "severely frail" cohort had increased odds of suffering from surgery-associated complications (OR 3.9 (CI 95%) 1.3-11.3)), but also had a high chance for postoperative functional improvements by KPS≥20 (OR 6.6 (CI95% 1.2-36.2)).
The mFI-5 and mFI-11 associate with postoperative mortality, complications, and functional benefit. Even though "severely frail" patients had the highest risk morbidity and mortality, they had the highest chance for functional improvement.
评估改良5项(mFI-5)和11项(mFI-11)因子衰弱指数是否与80岁以上幕上脑膜瘤患者的术后死亡率、并发症及功能获益相关。
从8个中心收集基线特征。根据患者术前状态和合并症,采用mFI-5和mFI-11评估衰弱情况。收集的评分分为“强健(mFI=0)”、“衰弱前期(mFI=1)”、“衰弱(mFI=2)”和“严重衰弱(mFI≥3)”。采用卡氏功能状态评分(KPS)评估结局;功能获益定义为KPS评分改善。此外,我们评估了患者术后的功能独立性(KPS≥70)。
研究人群包括262例患者(中位年龄83岁),术前KPS中位数为70(范围20至100)。90天和1年死亡率分别为9.0%和13.2%;我们记录了111例(42.4%)患者发生手术相关并发症。在术后第一年的最后随访时,101例(占38.5%)患者KPS评分改善,183例(占69.8%)患者获得或维持了功能独立性。“严重衰弱”患者在90天时死亡风险增加(比值比16.3(95%可信区间1.7-158.7)),在1年时也增加(比值比11.7(95%可信区间1.9-71.7));9例(占42.9%)严重衰弱患者在术后第一年内死亡。“严重衰弱”队列发生手术相关并发症的几率增加(比值比3.9(95%可信区间1.3-11.3)),但术后KPS评分提高≥20的功能改善机会也很高(比值比6.6(95%可信区间1.2-36.2))。
mFI-5和mFI-11与术后死亡率、并发症及功能获益相关。尽管“严重衰弱”患者发病和死亡风险最高,但他们功能改善的机会也最高。